Post-dural puncture headache in the obstetric patient
PDPH after labour epidural/spinal · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Obstetric patients are high-risk for PDPH after accidental dural puncture with a 16-18G Tuohy needle during epidural insertion, or after spinal. Early recognition and exclusion of dangerous mimics (pre-eclampsia, cerebral venous thrombosis, intracranial pathology) are essential before treating, as serious causes share features.
Red flags
- Loss of postural component or progressively worsening headache
- Hypertension, visual disturbance, epigastric pain (pre-eclampsia)
- Seizures, focal neurology or reduced consciousness (CVST/PRES/haemorrhage)
- Fever, neck stiffness (meningitis)
- New headache that is worst on lying flat (raised ICP)
Assessment
Differential diagnosis
- Pre-eclampsia / eclampsia
- Cerebral venous sinus thrombosis (increased peripartum risk)
- Posterior reversible encephalopathy syndrome (PRES)
- Migraine or tension headache
- Meningitis
- Subdural haematoma from chronic CSF leak
- Pneumocephalus (if loss-of-resistance to air used)
Investigations
- Confirm postural nature and link to a documented or suspected dural puncture
- BP, urinalysis and pre-eclampsia bloods (FBC, LFTs, urate, platelets)
- Neurological examination for focal signs, seizures or papilloedema
- Temperature/inflammatory markers if infection suspected
- MRI brain with venography if atypical features, focal neurology, seizures, or non-resolution (exclude CVST/other)
- Review anaesthetic chart: needle type/gauge, documented wet tap
Management
- Recognise the risk after any accidental dural puncture and warn/follow up the woman proactively
- Confirm the headache is postural and systematically EXCLUDE pre-eclampsia, CVST and other intracranial causes before attributing to PDPH
- Start conservative measures: hydration, regular paracetamol and NSAIDs, caffeine, and avoid constipation/straining
- Encourage mobilisation as tolerated and support with the newborn
- Offer an epidural blood patch for moderate-to-severe or persistent symptoms after informed consent (high efficacy in obstetrics)
- Perform EBP aseptically, injecting 15-20 mL autologous blood, stopping with back/leg discomfort
- Monitor for resolution and offer a repeat EBP if symptoms recur
- Maintain a high index of suspicion for CVST/subdural if the headache loses its postural character or neurology develops - image urgently
- Document thoroughly and provide written information with clear safety-netting and follow-up contact
- Consider thromboprophylaxis review given peripartum thrombotic risk while immobile
Drugs & doses
Paracetamol 1 g PO/IV QDS
Ibuprofen 400 mg PO TDS or diclofenac 50 mg PO TDS (NSAID, if no contraindication)
Caffeine 300-500 mg PO (or IV caffeine) once/twice daily
Autologous blood 15-20 mL epidural blood patch
Codeine/weak opioid for breakthrough pain (counsel re neonatal sedation if breastfeeding)
Disposition
Ward-based management with anaesthetic/obstetric follow-up and EBP as needed; urgent neuroimaging and specialist referral if red flags or atypical features emerge.
Complications & pitfalls
- Cranial nerve palsy (VI) and diplopia
- Subdural haematoma from untreated CSF leak
- Cerebral venous sinus thrombosis (increased risk if dehydrated/immobile)
- Chronic headache impairing newborn care
- EBP complications: repeat dural puncture, backache, infection
Exam pearls
- Peripartum women have a raised baseline risk of CVST and pre-eclampsia - never attribute a headache to PDPH without excluding these
- A 16-18G Tuohy wet tap carries a high PDPH risk; atraumatic pencil-point needles reduce spinal-related PDPH
- EBP is more effective after 24-48h than earlier
- Postural headache that becomes non-postural is a red flag for an alternative serious diagnosis
- Robust follow-up and written safety-netting are essential given early maternal discharge
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.